March 01, 2023
Hemab Therapeutics’ Statement Announcing the Planned Departure of Co-Founder and CTO Johan Faber
Media
February 28, 2023
Year-end report 2022
February 27, 2023
Aprea Therapeutics Announces Closing of $5.5 Million Underwritten Public Offering of Common Stock
February 22, 2023
Pulmonx Reports Fourth Quarter and Full Year 2022 Financial Results
February 21, 2023
HealthCap Portfolio Company Hemab Therapeutics raises $135M Series B Financing
February 21, 2023
Q4 2022 General Market Overview
February 16, 2023
BONESUPPORT HOLDING AB (publ) – publishes year-end report 2022
February 16, 2023
Oncopeptides publishes year-end report 2022
February 16, 2023
Targovax announces financing of up to NOK 300m over three years to advance its clinical cancer programs & pre-clinical circular RNA platform
February 16, 2023
Targovax ASA: Fourth quarter 2022 results